Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Goodwill (2016 - 2017)

Historic Goodwill for Pharma (IGC) over the last 8 years, with Q4 2017 value amounting to $198169.0.

  • Pharma's Goodwill rose 8.54% to $198169.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $198169.0, marking a year-over-year increase of 8.54%. This contributed to the annual value of $198169.0 for FY2017, which is 8321.95% down from last year.
  • Per Pharma's latest filing, its Goodwill stood at $198169.0 for Q4 2017, which was up 8.54% from $198169.0 recorded in Q3 2017.
  • Over the past 5 years, Pharma's Goodwill peaked at $1.2 million during Q1 2016, and registered a low of $198000.0 during Q4 2016.
  • Over the past 4 years, Pharma's median Goodwill value was $982782.0 (recorded in 2014), while the average stood at $695348.1.
  • Its Goodwill has fluctuated over the past 5 years, first skyrocketed by 2016.41% in 2016, then plummeted by 8321.95% in 2017.
  • Over the past 4 years, Pharma's Goodwill (Quarter) stood at $982782.0 in 2014, then changed by 0.0% to $982782.0 in 2015, then crashed by 79.85% to $198000.0 in 2016, then rose by 0.09% to $198169.0 in 2017.
  • Its last three reported values are $198169.0 in Q4 2017, $198169.0 for Q3 2017, and $198169.0 during Q2 2017.